Alfageme Fernando, Minguela Esther, Martínez Constanza, Salgüero Irene, Calvo Antonio, León Fernando, Álvarez Lourdes, de Vicente Olga, Panadero Francisco Javier, Salguero Oliver Luis, Roustán Gastón
Dermatology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
Centro de Salud Valle de la Oliva Majadahonda, Madrid, Spain.
J Ultrasound Med. 2021 Feb;40(2):351-356. doi: 10.1002/jum.15409. Epub 2020 Aug 7.
This study aimed to validate dermatologic ultrasound as a complementary teledermatologic imaging modality in primary and tertiary care centers.
Six primary care centers and 1 tertiary care dermatology department collaborated in the program. Images were sent through the institutional teledermatologic platform to the tertiary care dermatology department. At the reference hospital, ultrasound images and clinical data were received and registered by a physician trained in dermatologic ultrasound. An in-person consultation was scheduled to confirm the teleultrasound diagnosis. The time of response by the tertiary center, quality and size of the teledermatologic image, and concordance with the in-person diagnosis were assessed for each dermatologic lesion.
A total of 147 teleultrasound consultations with 143 patients (93 women and 50 men; mean age ± SD, 47 ± 23 years) were evaluated between June 2018 and January 2019. Nine teleultrasound consultations (6.1%) were not valid. Discordance between teleultrasound and the in-person diagnosis was evident in 6 of 138 cases (4.3%). Most cases corresponded to benign skin tumors (66.7%), followed by inflammatory skin lesions (15.9%), nonmelanoma skin lesions (13%), and other skin lesions (4.3%). All malignant tumors were detected (sensitivity, 100%), although 2 cases of benign lesions were telediagnosed as malignant (specificity, 97.8%). The positive and negative predictive values of a teleultrasound diagnosis of cutaneous malignancy were 90% and 100%, respectively.
Asynchronous primary care teleultrasound combined with dermatologic ultrasound training at tertiary centers is an effective teledermatologic modality.
本研究旨在验证皮肤超声作为初级和三级医疗中心辅助远程皮肤病学成像方式的有效性。
六个初级医疗中心和一个三级医疗皮肤科部门参与了该项目。图像通过机构远程皮肤病学平台发送至三级医疗皮肤科部门。在参考医院,由接受过皮肤超声培训的医生接收并记录超声图像和临床数据。安排面对面会诊以确认远程超声诊断。对每个皮肤病变评估三级中心的响应时间、远程皮肤病学图像的质量和大小,以及与面对面诊断的一致性。
2018年6月至2019年1月期间,共评估了147例远程超声会诊,涉及143例患者(93名女性和50名男性;平均年龄±标准差,47±23岁)。9例远程超声会诊(6.1%)无效。138例中有6例(4.3%)远程超声与面对面诊断存在明显不一致。大多数病例为良性皮肤肿瘤(66.7%),其次是炎症性皮肤病变(15.9%)、非黑色素瘤皮肤病变(13%)和其他皮肤病变(4.3%)。所有恶性肿瘤均被检测到(敏感性,100%),尽管有2例良性病变被远程诊断为恶性(特异性,97.8%)。皮肤恶性肿瘤远程超声诊断的阳性和阴性预测值分别为90%和100%。
异步初级医疗远程超声结合三级中心的皮肤超声培训是一种有效的远程皮肤病学方式。